Zdrowie i gospodarka · 13/01/1995

FDA Proposes Classification of Transilluminators for Breast Evaluation into Class III

The FDA is proposing to classify transilluminators used for breast evaluation into Class III, requiring premarket approval, following recommendations from the Obstetrics and Gynecology Devices Panel and public comments.